- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2364-3420
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting tumor cells with antibodies enhances anti-tumor immunity ; volume:4 ; number:5 ; day:29 ; month:10 ; year:2018 ; pages:243-253 ; date:10.2018
Biophysics reports ; 4, Heft 5 (29.10.2018), 243-253, 10.2018
- Urheber
-
Sun, Zhichen
Fu, Yang-Xin
Peng, Hua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s41048-018-0070-2
- URN
-
urn:nbn:de:101:1-2018123119174553142849
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sun, Zhichen
- Fu, Yang-Xin
- Peng, Hua
- SpringerLink (Online service)
Ähnliche Objekte (12)
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
TH9 cells in anti-tumor immunity
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
TH9 cells in anti-tumor immunity
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
TH9 cells in anti-tumor immunity
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity